Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Fundamental Analysis

NASDAQ:LFVN - Nasdaq - US53222K2050 - Common Stock - Currency: USD

12.83  +0.1 (+0.79%)

Fundamental Rating

6

Overall LFVN gets a fundamental rating of 6 out of 10. We evaluated LFVN against 35 industry peers in the Personal Care Products industry. While LFVN has a great health rating, its profitability is only average at the moment. A decent growth rate in combination with a cheap valuation! Better keep an eye on LFVN. This makes LFVN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year LFVN was profitable.
In the past year LFVN had a positive cash flow from operations.
Each year in the past 5 years LFVN has been profitable.
Each year in the past 5 years LFVN had a positive operating cash flow.
LFVN Yearly Net Income VS EBIT VS OCF VS FCFLFVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.71%, LFVN is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
LFVN has a Return On Equity of 24.56%. This is amongst the best in the industry. LFVN outperforms 82.86% of its industry peers.
LFVN has a better Return On Invested Capital (17.20%) than 80.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LFVN is significantly below the industry average of 16.32%.
The 3 year average ROIC (8.14%) for LFVN is below the current ROIC(17.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.71%
ROE 24.56%
ROIC 17.2%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
LFVN Yearly ROA, ROE, ROICLFVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150 200

1.3 Margins

LFVN has a Profit Margin of 3.46%. This is in the better half of the industry: LFVN outperforms 62.86% of its industry peers.
In the last couple of years the Profit Margin of LFVN has declined.
LFVN has a Operating Margin (5.11%) which is in line with its industry peers.
In the last couple of years the Operating Margin of LFVN has declined.
LFVN's Gross Margin of 79.79% is amongst the best of the industry. LFVN outperforms 97.14% of its industry peers.
In the last couple of years the Gross Margin of LFVN has remained more or less at the same level.
Industry RankSector Rank
OM 5.11%
PM (TTM) 3.46%
GM 79.79%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
LFVN Yearly Profit, Operating, Gross MarginsLFVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LFVN is creating value.
LFVN has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LFVN has less shares outstanding
There is no outstanding debt for LFVN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LFVN Yearly Shares OutstandingLFVN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
LFVN Yearly Total Debt VS Total AssetsLFVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 4.24 indicates that LFVN is not in any danger for bankruptcy at the moment.
LFVN has a better Altman-Z score (4.24) than 65.71% of its industry peers.
LFVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.24
ROIC/WACC1.89
WACC9.12%
LFVN Yearly LT Debt VS Equity VS FCFLFVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.66 indicates that LFVN should not have too much problems paying its short term obligations.
LFVN's Current ratio of 1.66 is in line compared to the rest of the industry. LFVN outperforms 48.57% of its industry peers.
LFVN has a Quick Ratio of 1.03. This is a normal value and indicates that LFVN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.03, LFVN is in line with its industry, outperforming 51.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.03
LFVN Yearly Current Assets VS Current LiabilitesLFVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

5

3. Growth

3.1 Past

LFVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.23%, which is quite impressive.
LFVN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.69% yearly.
Looking at the last year, LFVN shows a decrease in Revenue. The Revenue has decreased by -6.20% in the last year.
LFVN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.40% yearly.
EPS 1Y (TTM)26.23%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%23.81%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%21.13%

3.2 Future

The Earnings Per Share is expected to grow by 33.40% on average over the next years. This is a very strong growth
Based on estimates for the next years, LFVN will show a quite strong growth in Revenue. The Revenue will grow by 11.96% on average per year.
EPS Next Y37.17%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue Next Year13.91%
Revenue Next 2Y11.73%
Revenue Next 3Y11.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LFVN Yearly Revenue VS EstimatesLFVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
LFVN Yearly EPS VS EstimatesLFVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

LFVN is valuated correctly with a Price/Earnings ratio of 16.66.
Compared to the rest of the industry, the Price/Earnings ratio of LFVN indicates a somewhat cheap valuation: LFVN is cheaper than 71.43% of the companies listed in the same industry.
LFVN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.52, LFVN is valued correctly.
LFVN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LFVN is cheaper than 80.00% of the companies in the same industry.
LFVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.94.
Industry RankSector Rank
PE 16.66
Fwd PE 12.52
LFVN Price Earnings VS Forward Price EarningsLFVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

68.57% of the companies in the same industry are more expensive than LFVN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LFVN is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.5
EV/EBITDA 9.77
LFVN Per share dataLFVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of LFVN may justify a higher PE ratio.
LFVN's earnings are expected to grow with 33.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y32.94%
EPS Next 3Y33.4%

3

5. Dividend

5.1 Amount

LFVN has a Yearly Dividend Yield of 1.43%.
In the last 3 months the price of LFVN has falen by -23.73%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 5.69, LFVN pays a bit more dividend than its industry peers.
LFVN's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

LFVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
LFVN Yearly Dividends per shareLFVN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

LFVN pays out 26.61% of its income as dividend. This is a sustainable payout ratio.
DP26.61%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
LFVN Yearly Income VS Free CF VS DividendLFVN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
LFVN Dividend Payout.LFVN Dividend Payout, showing the Payout Ratio.LFVN Dividend Payout.PayoutRetained Earnings

LIFEVANTAGE CORP

NASDAQ:LFVN (5/22/2025, 10:18:56 AM)

12.83

+0.1 (+0.79%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners39.63%
Inst Owner Change45.7%
Ins Owners16%
Ins Owner Change-1.52%
Market Cap161.02M
Analysts82.5
Price Target33.15 (158.38%)
Short Float %19.49%
Short Ratio10.36
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0.55
Dividend Growth(5Y)N/A
DP26.61%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-30 2025-05-30 (0.045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.9%
Min EPS beat(2)-1.96%
Max EPS beat(2)61.77%
EPS beat(4)2
Avg EPS beat(4)13.46%
Min EPS beat(4)-34.64%
Max EPS beat(4)61.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.24%
Min Revenue beat(2)-7.05%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-5.92%
Min Revenue beat(4)-9.36%
Max Revenue beat(4)-1.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.43%
EPS NY rev (3m)0.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-3.94%
Revenue NY rev (3m)-3.43%
Valuation
Industry RankSector Rank
PE 16.66
Fwd PE 12.52
P/S 0.76
P/FCF 12.5
P/OCF 11.27
P/B 5.39
P/tB 5.43
EV/EBITDA 9.77
EPS(TTM)0.77
EY6%
EPS(NY)1.03
Fwd EY7.99%
FCF(TTM)1.03
FCFY8%
OCF(TTM)1.14
OCFY8.88%
SpS16.9
BVpS2.38
TBVpS2.36
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.71%
ROE 24.56%
ROCE 26.46%
ROIC 17.2%
ROICexc 36.36%
ROICexgc 36.85%
OM 5.11%
PM (TTM) 3.46%
GM 79.79%
FCFM 6.07%
ROA(3y)4.35%
ROA(5y)9.79%
ROE(3y)9.45%
ROE(5y)19.6%
ROIC(3y)8.14%
ROIC(5y)15.11%
ROICexc(3y)14.83%
ROICexc(5y)33.63%
ROICexgc(3y)15.14%
ROICexgc(5y)35.34%
ROCE(3y)12.51%
ROCE(5y)23.24%
ROICexcg growth 3Y-29.46%
ROICexcg growth 5Y-27.73%
ROICexc growth 3Y-29.25%
ROICexc growth 5Y-26.49%
OM growth 3Y-35.31%
OM growth 5Y-12.98%
PM growth 3Y-36.97%
PM growth 5Y-14.83%
GM growth 3Y-1.37%
GM growth 5Y-0.95%
F-Score7
Asset Turnover3.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.68%
Cap/Sales 0.66%
Interest Coverage 570.63
Cash Conversion 101.03%
Profit Quality 175.49%
Current Ratio 1.66
Quick Ratio 1.03
Altman-Z 4.24
F-Score7
WACC9.12%
ROIC/WACC1.89
Cap/Depr(3y)65.13%
Cap/Depr(5y)79.97%
Cap/Sales(3y)1.1%
Cap/Sales(5y)1.23%
Profit Quality(3y)232.22%
Profit Quality(5y)185.98%
High Growth Momentum
Growth
EPS 1Y (TTM)26.23%
EPS 3Y-16.88%
EPS 5Y-6.69%
EPS Q2Q%23.81%
EPS Next Y37.17%
EPS Next 2Y32.94%
EPS Next 3Y33.4%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-3.13%
Revenue growth 5Y-2.4%
Sales Q2Q%21.13%
Revenue Next Year13.91%
Revenue Next 2Y11.73%
Revenue Next 3Y11.96%
Revenue Next 5YN/A
EBIT growth 1Y193.9%
EBIT growth 3Y-37.33%
EBIT growth 5Y-15.06%
EBIT Next Year106.98%
EBIT Next 3Y42.08%
EBIT Next 5YN/A
FCF growth 1Y1363.75%
FCF growth 3Y-7.39%
FCF growth 5Y-8.22%
OCF growth 1Y365.51%
OCF growth 3Y-9.16%
OCF growth 5Y-7.27%